This poorer prognosis may be linked to the activation of IL-17, PI3K-Akt, TNF, P53, NF-kappaB, and HIF-1 signaling pathways, all of which are known to influence tumor angiogenesis and stemness [39–41]. The gene discussed is IL17A; the disease is neoplasm.